What are you looking for today?

Xu, Ke, Guidez, Fabien, Glasow, Annegret, Chung, Danna, Petrie, Kevin, Stegmaier, Kimberly, Wang, Kan-Kan, Zhang, Ji, Jing, Yongkui, Zelent, Arthur and Waxman, Samuel (2005) Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer research, 65 (17). pp. 7856-65. ISSN 0008-5472

Document

  • [thumbnail of 2005 Benzodithiophenes Potentiate Differentiation of Acute Promyelocytic Leukemia Cells.pdf]
    2005 Benzodithiophenes Potentiate Differentiation of Acute Promyelocytic Leukemia Cells.pdf - Published Version
    Restricted to Repository staff only

Abstract

Abstract

Differentiation induction is an effective therapy for acute promyelocytic leukemia (APL), which dramatically responds to all-trans-retinoic acid (ATRA). Recent studies have indicated that combinatorial use of retinoid and nonretinoid compounds, such as histone deacetylase inhibitors, arsenics, and PKA agonists, has higher therapeutic value in this disease and potentially in other malignancies. In a screen of 370 compounds, we identified benzodithiophene analogues as potent enhancers of ATRA-induced APL cell differentiation. These effects were not associated with changes in global histone acetylation and, for the most potent compounds, were exerted at very low nanomolar concentrations, and were paralleled by enhancement of some, but not all, ATRA-modulated gene expressions. Investigating the mechanism underlying the effects of these drugs on ATRA-induced APL cell differentiation, we have shown that benzodithiophenes enhance ATRA-mediated dissociation and association of corepressor N-CoR and coactivator p300 acetyltransferase, respectively, with retinoic acid receptor (RAR) alpha proteins. These data suggest that benzodithiophenes act at the level of receptor activation, possibly by affecting posttranslational modification of the receptor (and/or coregulators), thus leading to an enhancement in ATRA-mediated effects on gene expression and APL cell differentiation. Given the specificities of these low benzodithiophene concentrations for PML-RARalpha and RARalpha, these drugs may be useful for combinatorial differentiation therapy of APL and possibly other acute myelogenous leukemia subtypes in which the overall ATRA signaling is suppressed.

Item Type: Article
Depositing User: Kevin Petrie
URI: https://sure.sunderland.ac.uk/id/eprint/12424

Further Details

More Information

Depositing User

Identifiers

Item ID
12424
Identification Number
ISSN
0008-5472

Users with ORCIDS

ORCID for Kevin Petrie

Catalogue record

Date Deposited
18 Aug 2020 10:16
Last Modified
04 Jun 2025 16:19

Contributors

Author
Ke Xu
Author
Fabien Guidez
Author
Annegret Glasow
Author
Danna Chung
Author
Kimberly Stegmaier
Author
Kan-Kan Wang
Author
Ji Zhang
Author
Yongkui Jing
Author
Arthur Zelent
Author
Samuel Waxman

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year